Bhupat Mehta, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 67 Regent Dr, Oak Brook, IL 60523 Phone: 630-325-6151 Fax: 708-652-0058 |
News Archive
BioCryst Pharmaceuticals, Inc. announced that its partner, Shionogi & Co., Ltd. has received approval for an additional indication for use of intravenous (i.v.) peramivir to treat children and infants with influenza in Japan. In January 2010, Shionogi received the world's first approval for i.v. peramivir and launched it under the commercial name RAPIACTA® in Japan.
"In the run up to the U.N. summit on non-communicable diseases (NCDs), there are fears that industry interests might be trumping evidence-based public health interventions," BMJ reports.
Affymax, Inc. today reported financial results for the second quarter ended June 30, 2010. Net income for the second quarter of 2010 was $17.3 million compared to a net loss of $22.1 million for the second quarter of 2009. The company received milestone payments of $30.0 million from Takeda Pharmaceutical Company Limited for database lock of the Hematide/peginesatide Phase 3 clinical trials.
In direct contrast to previous reports, researchers now say that drinking gallons of orange juice and popping vitamin pills may not be a guarantee that you will live longer.
› Verified 1 days ago